Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Roth

Showing results (191-200 of 396) with videos related to

Pageof 40
Sort By:
Archives of General Psychiatry|May 5, 2004
Sleep in lifetime posttraumatic stress disorder: a community-based polysomnographic studyNaomi Breslau, Thomas Roth, Eleni Burduvali, et al.
Sleep|February 2, 2013
Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient studyThomas Roth, Andrew Krystal, Frank J Steinberg, et al.
Plos One|March 23, 2013
Sleep extension normalizes ERP of waking auditory sensory gating in healthy habitually short sleeping individualsValentina Gumenyuk, Oleg Korzyukov, Thomas Roth, et al.
Sleep Medicine|October 19, 2005
An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomniaThomas Roth, James K Walsh, Andrew Krystal, et al.
Sleep|January 29, 2008
Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter studyAndrew D Krystal, Milton Erman, Gary K Zammit, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 18, 2003
Caffeine reversal of ethanol effects on the multiple sleep latency test, memory, and psychomotor performanceChristopher L Drake, Timothy Roehrs, Lauren Turner, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|March 3, 2010
Effect of gaboxadol on patient-reported measures of sleep and waking function in patients with Primary Insomnia: results from two randomized, controlled, 3-month studiesThomas Roth, Christopher Lines, Kristel Vandormael, et al.
Sleep|April 13, 2018
A novel forehead temperature-regulating device for insomnia: a randomized clinical trialThomas Roth, David Mayleben, Neil Feldman, et al.
Sleep|July 7, 2011
Prevalence and polysomnographic correlates of insomnia comorbid with medical disordersRohit Budhiraja, Thomas Roth, David W Hudgel, et al.
Medicina (Kaunas, Lithuania)|August 26, 2022
Insomnia Complaints and Perceived Immune Fitness in Young Adults with and without Self-Reported Impaired Wound HealingJessica Balikji, Maarten M Hoogbergen, Johan Garssen, et al.
Pageof 40

Showing results (191-200 of 396) with videos related to

Sort By:
Pageof 40
Archives of General Psychiatry|May 5, 2004
Sleep in lifetime posttraumatic stress disorder: a community-based polysomnographic studyNaomi Breslau, Thomas Roth, Eleni Burduvali, et al.
Sleep|February 2, 2013
Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient studyThomas Roth, Andrew Krystal, Frank J Steinberg, et al.
Plos One|March 23, 2013
Sleep extension normalizes ERP of waking auditory sensory gating in healthy habitually short sleeping individualsValentina Gumenyuk, Oleg Korzyukov, Thomas Roth, et al.
Sleep Medicine|October 19, 2005
An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomniaThomas Roth, James K Walsh, Andrew Krystal, et al.
Sleep|January 29, 2008
Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter studyAndrew D Krystal, Milton Erman, Gary K Zammit, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 18, 2003
Caffeine reversal of ethanol effects on the multiple sleep latency test, memory, and psychomotor performanceChristopher L Drake, Timothy Roehrs, Lauren Turner, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|March 3, 2010
Effect of gaboxadol on patient-reported measures of sleep and waking function in patients with Primary Insomnia: results from two randomized, controlled, 3-month studiesThomas Roth, Christopher Lines, Kristel Vandormael, et al.
Sleep|April 13, 2018
A novel forehead temperature-regulating device for insomnia: a randomized clinical trialThomas Roth, David Mayleben, Neil Feldman, et al.
Sleep|July 7, 2011
Prevalence and polysomnographic correlates of insomnia comorbid with medical disordersRohit Budhiraja, Thomas Roth, David W Hudgel, et al.
Medicina (Kaunas, Lithuania)|August 26, 2022
Insomnia Complaints and Perceived Immune Fitness in Young Adults with and without Self-Reported Impaired Wound HealingJessica Balikji, Maarten M Hoogbergen, Johan Garssen, et al.
Pageof 40